RM

Rajat Malik

Director DIN 05303661
DIN 05303661 First appointment Aug 2012
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajat Malik

Data last updated:

Rajat Malik was a Director at Kannen Biosis Care Private Limited (from 2012) and Director at Kenvets Pharma Private Limited (from 2013).

DIN 05303661
First Appointment 13 Aug 2012
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kannen Biosis Care Private Limited U24233HR2012PTC046723
Director13 Aug 20122012Strike Off
Kenvets Pharma Private Limited U24100HR2013PTC049397
Director30 May 20132013₹12.8 Lakh (FY 2018)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kannen Biosis Care Private Limited
Kenvets Pharma Private Limited
Premium access

Shareholding and investment profile for Rajat Malik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajat Malik

Rajat Malik was first appointed on 13 Aug 2012 as Director at Kannen Biosis Care Private Limited. The most recent appointment on record is 30 May 2013 at Kenvets Pharma Private Limited.

Rajat Malik held 2 earlier board appointments: Kannen Biosis Care Private Limited (Director, from 13 Aug 2012); Kenvets Pharma Private Limited (Director, from 30 May 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available